Browsing by Author "Inoue E."

Now showing items 1-3 of 3

A new diagnostic indication device of a biomarker growth differentiation factor 15 for mitochondrial diseases: From laboratory to automated inspection

Koga Y.; Povalko N.; Inoue E.; Ishii A.; Fujii K.; Fujii T.; Murayama K.; Mogami Y.; Hata I.; Ikawa M.; Fukami K.; Fukumoto Y.; Nomura M.; Ichikawa K.; Yoshida K. (2020)

© 2020 The Authors. Journal of Inherited Metabolic Disease published by John Wiley & Sons Ltd on behalf of SSIEM. Mitochondrial diseases (MDs) are occasionally difficult to diagnose. Growth differentiation factor 15 ...
Biomarkers and clinical rating scales for sodium pyruvate therapy in patients with mitochondrial disease

Koga Y.; Povalko N.; Inoue E.; Nashiki K.; Tanaka M. (2019)

© 2019 Biomarkers and two clinical rating scales—the Japanese mitochondrial disease-rating scale (JMDRS) and Newcastle mitochondrial disease adult scale (NMDAS)—are clinically used when treating patients with mitochondrial ...
Therapeutic regimen of l-arginine for MELAS: 9-year, prospective, multicenter, clinical research

Koga Y.; Povalko N.; Inoue E.; Nakamura H.; Ishii A.; Suzuki Y.; Yoneda M.; Kanda F.; Kubota M.; Okada H.; Fujii K. (2018)

© 2018, The Author(s). Objective: To examine the efficacy and safety of the therapeutic regimen using oral and intravenous l-arginine for pediatric and adult patients with mitochondrial myopathy, encephalopathy, lactic ...

Now showing items 1-3 of 3

Search DSpace